Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 12 (2), 190-7

A T-cell HCV Vaccine Eliciting Effective Immunity Against Heterologous Virus Challenge in Chimpanzees

Affiliations

A T-cell HCV Vaccine Eliciting Effective Immunity Against Heterologous Virus Challenge in Chimpanzees

Antonella Folgori et al. Nat Med.

Abstract

Three percent of the world's population is chronically infected with the hepatitis C virus (HCV) and at risk of developing liver cancer. Effective cellular immune responses are deemed essential for spontaneous resolution of acute hepatitis C and long-term protection. Here we describe a new T-cell HCV genetic vaccine capable of protecting chimpanzees from acute hepatitis induced by challenge with heterologous virus. Suppression of acute viremia in vaccinated chimpanzees occurred as a result of massive expansion of peripheral and intrahepatic HCV-specific CD8(+) T lymphocytes that cross-reacted with vaccine and virus epitopes. These findings show that it is possible to elicit effective immunity against heterologous HCV strains by stimulating only the cellular arm of the immune system, and suggest a path for new immunotherapy against highly variable human pathogens like HCV, HIV or malaria, which can evade humoral responses.

Comment in

Similar articles

See all similar articles

Cited by 106 articles

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

Feedback